252 related articles for article (PubMed ID: 24253289)
1. In vivo evaluation of antibiotic activity against Mycobacterium abscessus.
Lerat I; Cambau E; Roth Dit Bettoni R; Gaillard JL; Jarlier V; Truffot C; Veziris N
J Infect Dis; 2014 Mar; 209(6):905-12. PubMed ID: 24253289
[TBL] [Abstract][Full Text] [Related]
2. Novel drug combination for Mycobacterium abscessus disease therapy identified in a Drosophila infection model.
Oh CT; Moon C; Park OK; Kwon SH; Jang J
J Antimicrob Chemother; 2014 Jun; 69(6):1599-607. PubMed ID: 24519481
[TBL] [Abstract][Full Text] [Related]
3. Synergistic activities of tigecycline with clarithromycin or amikacin against rapidly growing mycobacteria in Taiwan.
Huang CW; Chen JH; Hu ST; Huang WC; Lee YC; Huang CC; Shen GH
Int J Antimicrob Agents; 2013 Mar; 41(3):218-23. PubMed ID: 23312605
[TBL] [Abstract][Full Text] [Related]
4. Susceptibility of Mycobacterium abscessus to antimycobacterial drugs in preclinical models.
Obregón-Henao A; Arnett KA; Henao-Tamayo M; Massoudi L; Creissen E; Andries K; Lenaerts AJ; Ordway DJ
Antimicrob Agents Chemother; 2015 Nov; 59(11):6904-12. PubMed ID: 26303795
[TBL] [Abstract][Full Text] [Related]
5. Mycobacterium abscessus: an emerging rapid-growing potential pathogen.
Petrini B
APMIS; 2006 May; 114(5):319-28. PubMed ID: 16725007
[TBL] [Abstract][Full Text] [Related]
6. [Drug sensitivity analysis of Mycobacterium chelonae and Mycobacterium abscessus and evaluation of Etest for susceptibility testing].
Gui J; Wang F; Hong CY; Li JL; Liang J
Zhonghua Jie He He Hu Xi Za Zhi; 2013 Aug; 36(8):567-71. PubMed ID: 24252731
[TBL] [Abstract][Full Text] [Related]
7. GM-CSF knockout mice for preclinical testing of agents with antimicrobial activity against Mycobacterium abscessus.
De Groote MA; Johnson L; Podell B; Brooks E; Basaraba R; Gonzalez-Juarrero M
J Antimicrob Chemother; 2014 Apr; 69(4):1057-64. PubMed ID: 24222613
[TBL] [Abstract][Full Text] [Related]
8. Selection of Resistance to Clarithromycin in Mycobacterium abscessus Subspecies.
Mougari F; Bouziane F; Crockett F; Nessar R; Chau F; Veziris N; Sapriel G; Raskine L; Cambau E
Antimicrob Agents Chemother; 2017 Jan; 61(1):. PubMed ID: 27799212
[TBL] [Abstract][Full Text] [Related]
9.
Brown-Elliott BA; Wallace RJ
Antimicrob Agents Chemother; 2019 Feb; 63(2):. PubMed ID: 30509936
[TBL] [Abstract][Full Text] [Related]
10. In vitro evaluation of a new drug combination against clinical isolates belonging to the Mycobacterium abscessus complex.
Singh S; Bouzinbi N; Chaturvedi V; Godreuil S; Kremer L
Clin Microbiol Infect; 2014 Dec; 20(12):O1124-7. PubMed ID: 25185732
[TBL] [Abstract][Full Text] [Related]
11. Rifabutin Acts in Synergy and Is Bactericidal with Frontline Mycobacterium abscessus Antibiotics Clarithromycin and Tigecycline, Suggesting a Potent Treatment Combination.
Pryjma M; Burian J; Thompson CJ
Antimicrob Agents Chemother; 2018 Aug; 62(8):. PubMed ID: 29760147
[No Abstract] [Full Text] [Related]
12. Clinical significance of differentiation of Mycobacterium massiliense from Mycobacterium abscessus.
Koh WJ; Jeon K; Lee NY; Kim BJ; Kook YH; Lee SH; Park YK; Kim CK; Shin SJ; Huitt GA; Daley CL; Kwon OJ
Am J Respir Crit Care Med; 2011 Feb; 183(3):405-10. PubMed ID: 20833823
[TBL] [Abstract][Full Text] [Related]
13. In vitro efficacy of imipenem in combination with six antimicrobial agents against Mycobacterium abscessus.
Miyasaka T; Kunishima H; Komatsu M; Tamai K; Mitsutake K; Kanemitsu K; Ohisa Y; Yanagisawa H; Kaku M
Int J Antimicrob Agents; 2007 Sep; 30(3):255-8. PubMed ID: 17616451
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of antimicrobial susceptibilities of rapidly growing mycobacteria by Sensititre RAPMYCO panel.
Cavusoglu C; Gurpinar T; Ecemis T
New Microbiol; 2012 Jan; 35(1):73-6. PubMed ID: 22378556
[TBL] [Abstract][Full Text] [Related]
15. Macrolide treatment for Mycobacterium abscessus and Mycobacterium massiliense infection and inducible resistance.
Choi GE; Shin SJ; Won CJ; Min KN; Oh T; Hahn MY; Lee K; Lee SH; Daley CL; Kim S; Jeong BH; Jeon K; Koh WJ
Am J Respir Crit Care Med; 2012 Nov; 186(9):917-25. PubMed ID: 22878281
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of tedizolid against the Mycobacterium abscessus complex.
Compain F; Soroka D; Heym B; Gaillard JL; Herrmann JL; Dorchène D; Arthur M; Dubée V
Diagn Microbiol Infect Dis; 2018 Mar; 90(3):186-189. PubMed ID: 29217419
[TBL] [Abstract][Full Text] [Related]
17. In vitro activity between linezolid and other antimicrobial agents against Mycobacterium abscessus complex.
Zhang Z; Lu J; Song Y; Pang Y
Diagn Microbiol Infect Dis; 2018 Jan; 90(1):31-34. PubMed ID: 29089153
[TBL] [Abstract][Full Text] [Related]
18. Comparison of two-drug combinations, amikacin/tigecycline/imipenem and amikacin/tigecycline/clarithromycin against Mycobacteroides abscessus subsp. abscessus using the in vitro time-kill assay.
Portell-Buj E; Bonet-Rossinyol Q; López-Gavín A; Roman A; Fernández-Pittol M; Tudó G; Gonzalez-Martin J
J Antibiot (Tokyo); 2021 Apr; 74(4):285-290. PubMed ID: 33420382
[TBL] [Abstract][Full Text] [Related]
19. Rapidly growing members of the genus Mycobacterium affecting dogs and cats.
Jang SS; Hirsh DC
J Am Anim Hosp Assoc; 2002; 38(3):217-20. PubMed ID: 12022405
[TBL] [Abstract][Full Text] [Related]
20. Rapidly growing mycobacteria in Singapore, 2006-2011.
Tang SS; Lye DC; Jureen R; Sng LH; Hsu LY
Clin Microbiol Infect; 2015 Mar; 21(3):236-41. PubMed ID: 25658536
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
